$2.800
+0.061 (+2.19%)Zum Schluss
OMI-News
OMI-Events
Owens & Minor Renames to Accendra Health, Changes Ticker to ACH
Owens & Minor "announced that it will change its name to Accendra Health, Inc. with an anticipated effective date of December 31, 2025. The name change affects only the name of the parent corporation and is intended to better reflect the Company's strategic direction and future organizational focus as a leader in the home-based care market. The Company will continue to use and operate under the Apria and Byram Healthcare brands. In connection with the name change, the Company will change its ticker symbol to "ACH". The Company's common stock is expected to begin trading on the New York Stock Exchange under the new name and ticker symbol on January 2, 2026. Also on January 2nd, the Company will launch its new website, www.accendrahealth.com. All Company stock trading, filings, and market related information will be reported under the new symbol "ACH"."
Owens & Minor reaffirms FY25 adjusted EPS forecast of $1.02-$1.07, matching consensus at $1.02
Backs FY25 revenue view $2.76B-$2.82B, consensus $3.11B.
Owens & Minor announces Q3 adjusted EPS of 25 cents, surpassing consensus estimate of 23 cents.
Reports Q3 revenue $697.3M, consensus $704.06M. "Our recent announcement on the sale of our Products & Healthcare Services segment is another meaningful step in our strategy to pivot our focus to the more attractive home-based care space. We are keenly focused on reshaping our organization as one built around our Patient Direct platform and the long-term growth opportunities within home-based care. An example of this focus on growth is our recently announced nationwide preferred provider partnership agreement," said Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor.
Platinum to Purchase Owens & Minor's Products and Healthcare Services Division
Platinum Equity announced that it has entered into a definitive agreement to acquire the Products & Healthcare Services segment of Owens & Minor (OMI). Owens & Minor will retain a 5% interest in the business. Headquartered in Richmond, VA, P&HS is a vertically-integrated medical supply distribution platform primarily serving the acute care market. It is a leading national distributor of medical and surgical supplies for hospitals, health systems, and other healthcare providers across the United States. The transaction is expected to close near the end of the year, subject to regulatory review and other customary closing conditions. Bank of America (BAC) and Fifth Third (FITB) are serving as financial advisors to Platinum Equity on the P&HS acquisition. Gibson, Dunn & Crutcher is serving as legal advisor, Willkie Farr & Gallagher is serving as debt financing counsel, and Latham & Watkins (SWIM) is serving as special regulatory counsel to Platinum Equity on the transaction. Citi and Wells Fargo (WFC) are acting as financial advisors to Owens & Minor.
Owens & Minor to Sell Products and Healthcare Services Division for $375 Million
Owens & Minor announced that it has entered into a definitive agreement for the sale of the Company's Products & Healthcare Services segment to Platinum Equity. Over the last several years, Owens & Minor has been strategically moving towards expanding its leadership position in the very attractive home-based care space. This transaction will allow the Company to focus on a simpler business model and allow for a more appropriate valuation as a leader in this segment.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.